Momenta is a pharmaceutical company created in 2013 in Brazil by the Eurofarma Group, which sells products of various pharmaceutical classes in the country. Focusing on Medical Prescription, its initial portfolio is focused on acting in psychiatry, gynecology, respiratory system, among others.

The company is also responsible for the manufacture of antibiotics: penicillin, carbapenem and cephalosporin drugs, in different pharmaceutical forms, for human and veterinary use.

Momenta Generics

In 2022, the brand was internationalized and is currently responsible for all Generic products of the Eurofarma Group in the Latin American countries where the company operates. The project started in Ecuador and Colombia (where the brand was already established with a different visual identity). In 2023, it starts operating in Chile and Peru and should expand to other locations in the region.

Momenta Generics arrive in Latin America offering the population a wide portfolio of bioequivalent medicines that cover the indications and therapeutic classes most prescribed by doctors. The products, under the seal of the Eurofarma Group, guarantee consumers an affordable price, quality and effectiveness, seeking to democratize access to health.

Mission, Vision, Values

As a brand of the Eurofarma Group, Momenta shares the same ethical positioning, values ​​and principles that guided the group's corporate growth.

Mission

Promote access to health and quality of life with treatments at a fair price and profitable operations, which ensures the sustainable growth of the company and the sharing of value generated with employees and society.

Vision

We will be one of the 3 largest pharmaceutical companies with regional capital in Latin America, leaders in prescription drugs in Brazil and a benchmark in innovation and sustainability. With increasing profitability and 10% of the portfolio protected, 30% of sales will come from international operations.

Values

1. Agility: dynamism and simplicity are in our DNA, and to remain competitive, these attributes must be present throughout all company operations and processes;
2. Commitment: competency and commitment to the company foster employee valorization and growth. Therefore, we always strive to recognize our talents through internal promotion;
3. Sustainable development: strong management of human, financial and natural resources is based on the development and safety of employees, financial strength, healthy commercial practices and actions to preserve the environment – key points to balance our operations;
4. Focus on Health: our business model is based on participation across all pharmaceutical segments, through Business Units, International Operations and affiliates, maintaining a permanent dialogue, attracting and formalizing strategic partnerships;
5. Entrepreneurship: to anticipate the future, create new and better ways to steer the company in all areas, and go beyond the innovation inherent to R&D activities, our leaders are open to the "new" and strive to maintain the company’s pioneering spirit;
6. Ethics: in line with the company’s current Code, laws and regulations in force, we require our employees’ behavior to be based on ethics and transparency in all actions and operations performed at and on behalf of the company;
7. Equality (Diversity): we strive for a favorable and impartial environment where respect prevails. To that end, we have made commitments regarding diversity, justice and equality in the relations between employees and other stakeholders;
8. Reinvestment: knowing that taking risks is an integral part of dynamic and successful business, generating positive results drives the organization’s growth by reinvesting resources in the business itself;
9. Respect: we are proud of our trajectory, origins and ability to overcome. Our history is built to reflect our commitment to the growth of our employees and development of the countries in which we operate, while respecting the peoples and cultures with which we relate;
10. Results: we recognize the many different contributions in achieving our goals and share the generated wealth with employees and society through meritocracy programs, increased access and social investments.

Momenta is a pharmaceutical company created in 2013 in Brazil by the Eurofarma Group, which sells products of various pharmaceutical classes in the country. Focusing on Medical Prescription, its initial portfolio is focused on acting in psychiatry, gynecology, respiratory system, among others.

The company is also responsible for the manufacture of antibiotics: penicillin, carbapenem and cephalosporin drugs, in different pharmaceutical forms, for human and veterinary use.

Momenta Generics

In 2022, the brand was internationalized and is currently responsible for all Generic products of the Eurofarma Group in the Latin American countries where the company operates. The project started in Ecuador and Colombia (where the brand was already established with a different visual identity). In 2023, it starts operating in Chile and Peru and should expand to other locations in the region.

Momenta Generics arrive in Latin America offering the population a wide portfolio of bioequivalent medicines that cover the indications and therapeutic classes most prescribed by doctors. The products, under the seal of the Eurofarma Group, guarantee consumers an affordable price, quality and effectiveness, seeking to democratize access to health.

Mission, Vision, Values

As a brand of the Eurofarma Group, Momenta shares the same ethical positioning, values ​​and principles that guided the group's corporate growth.

Mission

Promote access to health and quality of life with treatments at a fair price and profitable operations, which ensures the sustainable growth of the company and the sharing of value generated with employees and society.

Vision

We will be one of the 3 largest pharmaceutical companies with regional capital in Latin America, leaders in prescription drugs in Brazil and a benchmark in innovation and sustainability. With increasing profitability and 10% of the portfolio protected, 30% of sales will come from international operations.

Values

1. Agility: dynamism and simplicity are in our DNA, and to remain competitive, these attributes must be present throughout all company operations and processes;
2. Commitment: competency and commitment to the company foster employee valorization and growth. Therefore, we always strive to recognize our talents through internal promotion;
3. Sustainable development: strong management of human, financial and natural resources is based on the development and safety of employees, financial strength, healthy commercial practices and actions to preserve the environment – key points to balance our operations;
4. Focus on Health: our business model is based on participation across all pharmaceutical segments, through Business Units, International Operations and affiliates, maintaining a permanent dialogue, attracting and formalizing strategic partnerships;
5. Entrepreneurship: to anticipate the future, create new and better ways to steer the company in all areas, and go beyond the innovation inherent to R&D activities, our leaders are open to the "new" and strive to maintain the company’s pioneering spirit;
6. Ethics: in line with the company’s current Code, laws and regulations in force, we require our employees’ behavior to be based on ethics and transparency in all actions and operations performed at and on behalf of the company;
7. Equality (Diversity): we strive for a favorable and impartial environment where respect prevails. To that end, we have made commitments regarding diversity, justice and equality in the relations between employees and other stakeholders;
8. Reinvestment: knowing that taking risks is an integral part of dynamic and successful business, generating positive results drives the organization’s growth by reinvesting resources in the business itself;
9. Respect: we are proud of our trajectory, origins and ability to overcome. Our history is built to reflect our commitment to the growth of our employees and development of the countries in which we operate, while respecting the peoples and cultures with which we relate;
10. Results: we recognize the many different contributions in achieving our goals and share the generated wealth with employees and society through meritocracy programs, increased access and social investments.

Momenta is a pharmaceutical company created in 2013 in Brazil by the Eurofarma Group, which sells products of various pharmaceutical classes in the country. Focusing on Medical Prescription, its initial portfolio is focused on acting in psychiatry, gynecology, respiratory system, among others.

The company is also responsible for the manufacture of antibiotics: penicillin, carbapenem and cephalosporin drugs, in different pharmaceutical forms, for human and veterinary use.

Momenta Generics

In 2022, the brand was internationalized and is currently responsible for all Generic products of the Eurofarma Group in the Latin American countries where the company operates. The project started in Ecuador and Colombia (where the brand was already established with a different visual identity). In 2023, it starts operating in Chile and Peru and should expand to other locations in the region.

Momenta Generics arrive in Latin America offering the population a wide portfolio of bioequivalent medicines that cover the indications and therapeutic classes most prescribed by doctors. The products, under the seal of the Eurofarma Group, guarantee consumers an affordable price, quality and effectiveness, seeking to democratize access to health.

Mission, Vision, Values

As a brand of the Eurofarma Group, Momenta shares the same ethical positioning, values ​​and principles that guided the group's corporate growth.

Mission

Promote access to health and quality of life with treatments at a fair price and profitable operations, which ensures the sustainable growth of the company and the sharing of value generated with employees and society.

Vision

We will be one of the 3 largest pharmaceutical companies with regional capital in Latin America, leaders in prescription drugs in Brazil and a benchmark in innovation and sustainability. With increasing profitability and 10% of the portfolio protected, 30% of sales will come from international operations.

Values

1. Agility: dynamism and simplicity are in our DNA, and to remain competitive, these attributes must be present throughout all company operations and processes;
2. Commitment: competency and commitment to the company foster employee valorization and growth. Therefore, we always strive to recognize our talents through internal promotion;
3. Sustainable development: strong management of human, financial and natural resources is based on the development and safety of employees, financial strength, healthy commercial practices and actions to preserve the environment – key points to balance our operations;
4. Focus on Health: our business model is based on participation across all pharmaceutical segments, through Business Units, International Operations and affiliates, maintaining a permanent dialogue, attracting and formalizing strategic partnerships;
5. Entrepreneurship: to anticipate the future, create new and better ways to steer the company in all areas, and go beyond the innovation inherent to R&D activities, our leaders are open to the "new" and strive to maintain the company’s pioneering spirit;
6. Ethics: in line with the company’s current Code, laws and regulations in force, we require our employees’ behavior to be based on ethics and transparency in all actions and operations performed at and on behalf of the company;
7. Equality (Diversity): we strive for a favorable and impartial environment where respect prevails. To that end, we have made commitments regarding diversity, justice and equality in the relations between employees and other stakeholders;
8. Reinvestment: knowing that taking risks is an integral part of dynamic and successful business, generating positive results drives the organization’s growth by reinvesting resources in the business itself;
9. Respect: we are proud of our trajectory, origins and ability to overcome. Our history is built to reflect our commitment to the growth of our employees and development of the countries in which we operate, while respecting the peoples and cultures with which we relate;
10. Results: we recognize the many different contributions in achieving our goals and share the generated wealth with employees and society through meritocracy programs, increased access and social investments.

Momenta is a pharmaceutical company created in 2013 in Brazil by the Eurofarma Group, which sells products of various pharmaceutical classes in the country. Focusing on Medical Prescription, its initial portfolio is focused on acting in psychiatry, gynecology, respiratory system, among others.

The company is also responsible for the manufacture of antibiotics: penicillin, carbapenem and cephalosporin drugs, in different pharmaceutical forms, for human and veterinary use.

Momenta Generics

In 2022, the brand was internationalized and is currently responsible for all Generic products of the Eurofarma Group in the Latin American countries where the company operates. The project started in Ecuador and Colombia (where the brand was already established with a different visual identity). In 2023, it starts operating in Chile and Peru and should expand to other locations in the region.

Momenta Generics arrive in Latin America offering the population a wide portfolio of bioequivalent medicines that cover the indications and therapeutic classes most prescribed by doctors. The products, under the seal of the Eurofarma Group, guarantee consumers an affordable price, quality and effectiveness, seeking to democratize access to health.

Mission, Vision, Values

As a brand of the Eurofarma Group, Momenta shares the same ethical positioning, values ​​and principles that guided the group's corporate growth.

Mission

Promote access to health and quality of life with treatments at a fair price and profitable operations, which ensures the sustainable growth of the company and the sharing of value generated with employees and society.

Vision

We will be one of the 3 largest pharmaceutical companies with regional capital in Latin America, leaders in prescription drugs in Brazil and a benchmark in innovation and sustainability. With increasing profitability and 10% of the portfolio protected, 30% of sales will come from international operations.

Values

1. Agility: dynamism and simplicity are in our DNA, and to remain competitive, these attributes must be present throughout all company operations and processes;
2. Commitment: competency and commitment to the company foster employee valorization and growth. Therefore, we always strive to recognize our talents through internal promotion;
3. Sustainable development: strong management of human, financial and natural resources is based on the development and safety of employees, financial strength, healthy commercial practices and actions to preserve the environment – key points to balance our operations;
4. Focus on Health: our business model is based on participation across all pharmaceutical segments, through Business Units, International Operations and affiliates, maintaining a permanent dialogue, attracting and formalizing strategic partnerships;
5. Entrepreneurship: to anticipate the future, create new and better ways to steer the company in all areas, and go beyond the innovation inherent to R&D activities, our leaders are open to the "new" and strive to maintain the company’s pioneering spirit;
6. Ethics: in line with the company’s current Code, laws and regulations in force, we require our employees’ behavior to be based on ethics and transparency in all actions and operations performed at and on behalf of the company;
7. Equality (Diversity): we strive for a favorable and impartial environment where respect prevails. To that end, we have made commitments regarding diversity, justice and equality in the relations between employees and other stakeholders;
8. Reinvestment: knowing that taking risks is an integral part of dynamic and successful business, generating positive results drives the organization’s growth by reinvesting resources in the business itself;
9. Respect: we are proud of our trajectory, origins and ability to overcome. Our history is built to reflect our commitment to the growth of our employees and development of the countries in which we operate, while respecting the peoples and cultures with which we relate;
10. Results: we recognize the many different contributions in achieving our goals and share the generated wealth with employees and society through meritocracy programs, increased access and social investments.